Coronavirus Covid-19 Information

Complementary and alternative medicine use in oncology

Dr Aoife Ryan and her team in UCC in collaboration with the Irish Cancer Society are conducting research on complementary and alternative medicine use in Oncology.

They hope that the results of this study will help healthcare professionals better support the needs of Irish cancer survivors. The results will be analysed at University College Cork.

Please see below links for more information

Healthcare professional survey

Survivor survey

Development of a Risk Reduction Patient Decision Aid Toolkit for Women with a BRCA+ Gene Mutation

Women with a genetic mutation in the BRCA1 or BRCA2 genes have an elevated lifetime risk of developing breast and ovarian cancer. To address this risk, women are managed with a combination of radiological surveillance and/or risk-reduction strategies such as prophylactic surgery or risk-reducing medication.

This project aims to develop a web-based BRCA+ Risk Reduction Patient Decision Aid (PtDA) Toolkit. The BRCA+ Risk Reduction PtDA Toolkit will provide women with BRCA+ gene mutation with information to make informed decisions about BRCA+ cancer risk-reduction strategies.

BRCA+ Gene Mutation